SB 15 - VERSION ADOPTED BY BOTH BODIES
2017 SESSION
17-0516
01/04
SENATE BILL 15
AN ACT relative to the law regarding therapeutic use of cannabis.
SPONSORS: Sen. Reagan, Dist 17
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
This bill adds a new qualifying medical condition for the purposes of receiving cannabis for therapeutic use.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
17-0516
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Seventeen
AN ACT relative to the law regarding therapeutic use of cannabis.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Use of Cannabis for Therapeutic Purposes. Amend RSA 126-X:1, IX(a) to read as follows:
IX.(a)(1) "Qualifying medical condition'' means the presence of:
[(1)] (A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C currently receiving antiviral treatment, amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and
[(2)] (B) A severely debilitating or terminal medical condition or its treatment that has produced at least one of the following: elevated intraocular pressure, cachexia, chemotherapy-induced anorexia, wasting syndrome, agitation of Alzheimer's disease, severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects, constant or severe nausea, moderate to severe vomiting, seizures, or severe, persistent muscle spasms[.]; or
(2) "Qualifying medical condition" also means severe pain that has not responded to previously prescribed medication or surgical measures or for which other treatment options produced serious side effects.
2 Effective Date. This act shall take effect 60 days after its passage.
| Date | Body | Type |
|---|---|---|
| Jan. 10, 2017 | Senate | Hearing |
| Jan. 19, 2017 | Senate | Floor Vote |
| March 21, 2017 | House | Hearing |
| March 22, 2017 | House | Exec Session |
| April 20, 2017 | House | Floor Vote |
: Died on Table
May 4, 2017: Lay on Table (Rep. Kotowski): MA VV 05/04/2017
May 4, 2017: Reconsider SB 15 (Rep. Cushing): MA VV 05/04/2017
April 20, 2017: Ought to Pass: MA VV 04/20/2017 HJ 14 P. 10
April 20, 2017: Committee Report: Ought to Pass for 04/20/2017 (Vote 17-2; RC) HC 20 P. 8
March 22, 2017: Executive Session: 03/22/2017 09:00 AM LOB 205
March 21, 2017: Public Hearing: 03/21/2017 10:00 AM LOB 205
Feb. 16, 2017: Introduced 02/16/2017 and referred to Health, Human Services and Elderly Affairs HJ 8 P. 44
Jan. 19, 2017: Ought to Pass: MA, VV; OT3rdg; 01/19/2017; SJ 4
Jan. 19, 2017: Sen. Bradley Withdraws Floor Amendment 2017-0048s; 01/19/2017; SJ 4
Jan. 19, 2017: Sen. Bradley Offered Floor Amendment # 2017-0048s; 01/19/2017; SJ 4
Jan. 19, 2017: Committee Report: Ought to Pass, 01/19/2017; SC 6
Jan. 10, 2017: Hearing: 01/10/2017, Room 101, LOB, 01:30 pm; SC 5
Jan. 5, 2017: To Be Introduced 01/05/2017 and Referred to Health and Human Services; SJ 4